Cancer Family
Intraepithelial Neoplasia
CI-CAN-00000210Explore in graph →
Non-malignant79 active trials
- NCIt
- C8366
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000210Explore in graph →
Clinical trials
491 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05051722 | Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer(ECHO) | recruiting | — | 3,110 | Mayo ClinicOTHER | 1 | Sep 29, 2026 | clinicaltrials |
| NCT06949800 | CASCADE 2002: PROTECT Study, "PRObiotics to TrEat Anal preCancer Trial | recruiting | Phase 2 | 90 | University of California, San FranciscoOTHER | 2 | Sep 15, 2026 |
| NCT05316935 | GnRHa + Letrozole in Non-obese Progestin-insensitive Endometrial Cancer and Atypical Hyperplasia Patients | recruiting | Phase 2 / Phase 3 | 80 | Xiaojun ChenOTHER | 1 | Sep 10, 2026 | clinicaltrials |
| NCT06379113 | GnRHa + Letrozole in Obese Progestin-insensitive Endometrial Cancer Patients | recruiting | Phase 2 / Phase 3 | 29 | Xiaojun ChenOTHER | 1 | Sep 10, 2026 | clinicaltrials |
| NCT04839614 | Concurrent Laparoscopic Hysterectomy and Weight Loss Surgery in Obese Patients With Endometrial Carcinoma or Endometrial Intraepithelial Neoplasia | recruiting | N/A | 30 | Dana-Farber Cancer InstituteOTHER | 1 | Aug 31, 2026 | clinicaltrials |
| NCT07461818 | Point of Care - Triage and Treatment for Cervical Pre-cancer(POC) | recruiting | N/A | 5,000 | Basic Health International, Inc.OTHER | 1 | Aug 28, 2026 | clinicaltrials |
| NCT07544680 | Endometrial Cancer Vaginal Fluid Specimen Collection Study(ENVISION) | recruiting | — | 4,200 | Exact Sciences CorporationINDUSTRY | 1 | Aug 27, 2026 | clinicaltrials |
| NCT05463796 | InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer | recruiting | — | 5,000 | Dana-Farber Cancer InstituteOTHER | 1 | Aug 17, 2026 | clinicaltrials |
| NCT07429071 | Effectiveness of a Vaginal Gel on CIN1/2 Regression and HPV Clearance. | recruiting | N/A | 70 | University of AarhusOTHER | 1 | Aug 3, 2026 | clinicaltrials |
| NCT06184750 | Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial | recruiting | Phase 2 | 200 | National Cancer Institute (NCI)NIH | 1 | Jul 27, 2026 | clinicaltrials |
| NCT06191133 | Fenofibrate in Patients With Cervical Intraepithelial Neoplasia and Invasive Cervical Carcinoma | recruiting | Phase 1 | 24 | Lindsay Ferguson, MDOTHER | 1 | Jul 27, 2026 | clinicaltrials |
| NCT05028725 | Novel Strategy for Early Detection of Esophageal Squamous Cell Carcinoma | recruiting | N/A | 289 | University of California, San FranciscoOTHER | 1 | Jul 23, 2026 | clinicaltrials |
| NCT06979180 | A Clinical Trial to Investigate the Safety and Efficacy of Papillex® on Abnormal Cervical Cells Caused by HPV. | recruiting | N/A | 60 | Papillex Inc.INDUSTRY | 1 | Jul 8, 2026 | clinicaltrials |
| NCT06342440 | Early Detection of Advanced Adenomas and Colorectal Cancer(AACRC) | recruiting | — | 2,000 | City of Hope Medical CenterOTHER | 5 | Jul 7, 2026 | clinicaltrials |
| NCT04131413 | HPV DNA Vaccine Via Electroporation for HPV16 Positive Cervical Neoplasia | recruiting | Phase 1 | 48 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Jul 2, 2026 | clinicaltrials |
| NCT05178498 | Impact of Dietary Inflammatory Potential on Breast Cancer Risk | recruiting | — | 960 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Jun 12, 2026 | clinicaltrials |
| NCT03913117 | Study of Treatment for HPV16+ ASC-US or LSIL(PVX-6) | recruiting | Phase 1 | 30 | University of Alabama at BirminghamOTHER | 1 | May 15, 2026 | clinicaltrials |
| NCT05334004 | Lopinavir/Ritonavir in PLWH With High-Grade AIN | recruiting | Phase 1 | 21 | University of Wisconsin, MadisonOTHER | 1 | May 15, 2026 | clinicaltrials |
| NCT07572396 | Phase II Study of Dysplasix™ Intravaginal Suppositories in Patients Patients With High-Risk HPV and Mild Cervical Cytologic Abnormalities | recruiting | Phase 2 | 45 | Amplexd Therapeutics, Inc.INDUSTRY | 1 | May 14, 2026 | clinicaltrials |
| NCT07454915 | PVX4 for the Treatment of Human Papilloma Virus (HPV)16+ Cervical Dysplasia | recruiting | Phase 2 | 138 | PapiVax Biotech, Inc.OTHER | 2 | May 6, 2026 | clinicaltrials |
| NCT07029152 | Screening for Anal Cancer in Men Who Have Sex With Men Using Pre-Exposure Prophylaxis(SCOPE) | recruiting | N/A | 296 | Universitair Ziekenhuis BrusselOTHER | 1 | May 1, 2026 | clinicaltrials |
| NCT07377734 | Intrauterine Injection of Type III Collage in FST of EC/AEH(2026ColECFerSp) | recruiting | Phase 2 | 30 | Wang JianliuOTHER | 1 | Mar 30, 2026 | clinicaltrials |
| NCT04226313 | Self-sampling for Non-attenders to Cervical Cancer Screening(KOPRETINA) | recruiting | N/A | 15,000 | The Institute of Molecular and Translational Medicine, Czech RepublicOTHER | 1 | Mar 23, 2026 | clinicaltrials |
| NCT04312633 | Clinical Utility of WATS3D: A 5-Year Prospective Study | recruiting | — | 90,000 | CDx DiagnosticsINDUSTRY | 1 | Mar 20, 2026 | clinicaltrials |
| NCT07480902 | Comparison Between Liquid-Based Cytology And Molecular Screening For Detecting Precursor Lesions and Cervical Cancer | recruiting | N/A | 558 | Timser SAPI de CVINDUSTRY | 1 | Mar 18, 2026 | clinicaltrials |
| NCT04712851 | Pembrolizumab for the Treatment of Cervical Intraepithelial Neoplasia | recruiting | Phase 2 | 25 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Mar 10, 2026 | clinicaltrials |
| NCT07372248 | Thermal Artifact in Patients Undergoing Conization: A Clinical Study | recruiting | N/A | 150 | Saglik Bilimleri UniversitesiOTHER | 1 | Mar 2, 2026 | clinicaltrials |
| NCT05774561 | Role of Liquid Biopsies in HPV-associated Cancer Treatment Monitoring | recruiting | — | 480 | The Institute of Molecular and Translational Medicine, Czech RepublicOTHER | 1 | Feb 12, 2026 | clinicaltrials |
| NCT06815939 | Validation of a Lab-free Low-cost Screening Test for Prevention of Cervical Cancer(OPTICS) | recruiting | N/A | 10,000 | DL AnalyticsINDUSTRY | 1 | Jan 29, 2026 | clinicaltrials |
| NCT07275333 | Human Papillomavirus Self-sampling for Enhancing Cervical Screening During the War in Ukraine | recruiting | N/A | 1,000 | Karolinska InstitutetOTHER | 1 | Dec 18, 2025 | clinicaltrials |
| NCT04098744 | Artesunate Vaginal Inserts for the Treatment of Cervical Intraepithelial Neoplasia (CIN2/3)(ART-CIN_IIB) | recruiting | Phase 2 | 78 | Frantz Viral Therapeutics, LLCINDUSTRY | 1 | Oct 2, 2025 | clinicaltrials |
| NCT05606133 | Circulating Human Papilloma Virus (HPV) DNA for the Screening and Surveillance of Gynecologic Cancers | recruiting | N/A | 100 | Northwell HealthOTHER | 1 | Sep 23, 2025 | clinicaltrials |
| NCT06075264 | Phase II Study of Artesunate Ointment for the Treatment of Vulvar High Grade Squamous Intraepithelial Lesions (Vulvar HSIL, VIN2/3)(ART-VIN IIB) | recruiting | Phase 2 | 27 | Frantz Viral Therapeutics, LLCINDUSTRY | 1 | Aug 14, 2025 | clinicaltrials |
| NCT07117045 | Artificial Intelligence-powered Low-Dose Computed Tomography for Screening of Pancreatic Cancer(AI-LDCT-PC) | recruiting | — | 400,000 | Changhai HospitalOTHER | 1 | Aug 12, 2025 | clinicaltrials |
| NCT06967740 | Epidemiological Factors and Optimization of Conservative Approaches to Precancerous Lesions of Female Reproductive Organs | recruiting | — | 200 | Nikola JanovskaOTHER_GOV | 1 | Jul 31, 2025 | clinicaltrials |
| NCT03061435 | Screening for Anal Cancer in Women With High-grade Vulvar Dysplasia or Vulvar Cancer.(Vulvar-AIN) | recruiting | N/A | 110 | Dr. Danielle VicusOTHER | 1 | May 16, 2025 | clinicaltrials |
| NCT05647109 | Patient-derived Tumor-like Cell Clusters Predict Progesterone Sensitivity in Patients With Early Endometrial Cancer | recruiting | — | 244 | Peking University People's HospitalOTHER | 1 | May 4, 2025 | clinicaltrials |
| NCT05266898 | Immunogenicity of Gardasil-9 HPV Vaccine in People Living With HIV(AGO-Gard) | recruiting | Phase 4 | 250 | Louisiana State University Health Sciences Center in New OrleansOTHER | 1 | Apr 18, 2025 | clinicaltrials |
| NCT05284877 | The Organ Transplant Recipient HPV and Skin Cancer Study | recruiting | — | 1,500 | Merete HaedersdalOTHER | 1 | Apr 1, 2025 | clinicaltrials |
| NCT06078514 | Sexual Function and Quality of Life After LEEP: a Prospective Multi-Center Study(SEQUEL) | recruiting | — | 1,000 | Tampere University HospitalOTHER | 1 | Mar 20, 2025 | clinicaltrials |
| NCT05229679 | HPV-based Screening Among Women 23-29 Years of Age | recruiting | N/A | 180,000 | Karolinska InstitutetOTHER | 1 | Mar 19, 2025 | clinicaltrials |
| NCT05640700 | Vaginal Microbiome and HPV Pre-malignant and Cervical Dysplasia | recruiting | — | 90 | Hadassah Medical OrganizationOTHER | 1 | Mar 19, 2025 | clinicaltrials |
| NCT05078528 | Low-cost Imaging Technology for Global Prevention of Cervical Cancer | recruiting | N/A | 1,060 | Barretos Cancer HospitalOTHER | 1 | Feb 6, 2025 | clinicaltrials |
| NCT04772937 | Comparison of LLETZ Versus LEEP for the Treatment of Cervical Dysplasia | recruiting | N/A | 206 | Ruhr University of BochumOTHER | 1 | Jan 30, 2025 | clinicaltrials |
| NCT06611020 | Adjuvant VaccInation After Conization for the Treatment for CervicAL Dysplasia(VITAL) | recruiting | — | 600 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 1 | Sep 26, 2024 | clinicaltrials |
| NCT05282095 | Effect of HPV Integration on Prognosis of Young Women With CIN2 in China | recruiting | — | 300 | Fujian Maternity and Child Health HospitalOTHER | 1 | Sep 19, 2024 | clinicaltrials |
| NCT06598176 | Developing a Combined Molecular Screening and Triage Test for Cervical Cancer in Self-samples(COMBISCREEN) | recruiting | N/A | 100 | Universiteit AntwerpenOTHER | 1 | Sep 19, 2024 | clinicaltrials |
| NCT04422366 | Evaluate the Efficacy, Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females | recruiting | Phase 3 | 8,000 | Shanghai Bovax Biotechnology Co., Ltd.INDUSTRY | 1 | Jun 7, 2024 | clinicaltrials |
| NCT06326294 | Assessment of the Effectiveness of TA Versus LEEP for Cervical Cancer Risk Reduction in WLHIV in Mozambique | recruiting | N/A | 4,844 | Instituto Nacional de Saúde, MozambiqueOTHER_GOV | 1 | May 22, 2024 | clinicaltrials |
| NCT06389448 | Comparison of pCLE and EB in Gastric Lesion Diagnosis | recruiting | N/A | 366 | Huazhong University of Science and TechnologyOTHER | 1 | May 7, 2024 | clinicaltrials |
Data updated 19 hours agoSource updated Sep 29, 2026source: clinicaltrials